US Drug Recall Register
Class II · Moderate risk Terminated Initiated May 15, 2020 (6 years ago)

Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed dissolution specifications

What was recalled

Doxycycline Hyclate tablets USP, 100 mg, packaged in bottles a) 6-count (NDC 55289-866-06), b) 10-count (NDC 55289-866-10), c) 14-count (NDC 55289-866-14), d) 20-count (NDC 55289-866-20), e) 28-count (NDC 55289-866-28), f) 30-count (NDC 55289-866-30), g) 60-count (NDC 55289-866-60), h) 120-count (NDC 55289-866-98), i) 210-count (NDC 55289-866-71), j) 300-count (NDC 55289-866-87), k) 400-count (NDC 55289-866-74), Rx only, PD-Rx Pharmaceuticals Incorporated Oklahoma City, OK 73127

Recalling firm
PD-Rx Pharmaceuticals, Inc.
NDC code
55289-866-06
Origin
OK, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1276-2020

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Doxycycline recalls

See all